These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 22868231)
1. Physicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: interaction with model membranes. Sánchez-Martín MJ; Cruz A; Busquets MA; Haro I; Alsina MA; Pujol M Int J Pharm; 2012 Oct; 436(1-2):593-601. PubMed ID: 22868231 [TBL] [Abstract][Full Text] [Related]
2. Biophysical investigations of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide. Sánchez-Martín MJ; Urbán P; Pujol M; Haro I; Alsina MA; Busquets MA Chemphyschem; 2011 Oct; 12(15):2816-22. PubMed ID: 21905195 [TBL] [Abstract][Full Text] [Related]
3. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C. Sánchez-Martín MJ; Hristova K; Pujol M; Gómara MJ; Haro I; Alsina MA; Busquets MA J Colloid Interface Sci; 2011 Aug; 360(1):124-31. PubMed ID: 21565353 [TBL] [Abstract][Full Text] [Related]
4. Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition. Galatola R; Cruz A; Gómara MJ; Prat J; Alsina MA; Haro I; Pujol M Biochim Biophys Acta; 2015 Feb; 1848(2):392-407. PubMed ID: 25450346 [TBL] [Abstract][Full Text] [Related]
5. Effect of E1(64-81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models. Sánchez-Martín MJ; Busquets MA; Girona V; Haro I; Alsina MA; Pujol M Biochim Biophys Acta; 2011 Sep; 1808(9):2178-88. PubMed ID: 21672514 [TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide. Herrera E; Gomara MJ; Mazzini S; Ragg E; Haro I J Phys Chem B; 2009 May; 113(20):7383-91. PubMed ID: 19402654 [TBL] [Abstract][Full Text] [Related]
7. Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage. Fernández-Vidal M; Rojo N; Herrera E; Gómara MJ; Haro I Biophys Chem; 2008 Jan; 132(1):55-63. PubMed ID: 17988786 [TBL] [Abstract][Full Text] [Related]
8. Study of adsorption and penetration of E2(279-298) peptide into Langmuir phospholipid monolayers. Larios C; Miñones J; Haro I; Alsina MA; Busquets MA; Trillo JM J Phys Chem B; 2006 Nov; 110(46):23292-9. PubMed ID: 17107178 [TBL] [Abstract][Full Text] [Related]
9. Effects of overlapping GB virus C/hepatitis G virus synthetic peptides on biomembrane models. Larios C; Busquets MA; Carilla J; Alsina MA; Haro I Langmuir; 2004 Dec; 20(25):11149-60. PubMed ID: 15568870 [TBL] [Abstract][Full Text] [Related]
10. Modification of FP-HIV activity by peptide sequences of GB virus C: a biophysical approach. Domènech O; Ortiz A; Pujol M; Haro I; Muñoz M; Alsina MA; Prat J; Busquets MA; Girona V Biochim Biophys Acta; 2014 May; 1838(5):1274-80. PubMed ID: 24530897 [TBL] [Abstract][Full Text] [Related]
11. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins. Lev N; Shai Y J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659 [TBL] [Abstract][Full Text] [Related]
12. Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes. Deshayes S; Plénat T; Aldrian-Herrada G; Divita G; Le Grimellec C; Heitz F Biochemistry; 2004 Jun; 43(24):7698-706. PubMed ID: 15196012 [TBL] [Abstract][Full Text] [Related]
13. Fusogenic activity of hepadnavirus peptides corresponding to sequences downstream of the putative cleavage site. Rodríguez-Crespo I; Núñez E; Yélamos B; Gómez-Gutiérrez J; Albar JP; Peterson DL; Gavilanes F Virology; 1999 Aug; 261(1):133-42. PubMed ID: 10441561 [TBL] [Abstract][Full Text] [Related]
14. Interaction of a peptide from the pre-transmembrane domain of the severe acute respiratory syndrome coronavirus spike protein with phospholipid membranes. Guillén J; Moreno MR; Pérez-Berna AJ; Bernabeu A; Villalaín J J Phys Chem B; 2007 Dec; 111(49):13714-25. PubMed ID: 18020324 [TBL] [Abstract][Full Text] [Related]
15. Biophysical characterization of the fusogenic region of HCV envelope glycoprotein E1. Pérez-Berná AJ; Pabst G; Laggner P; Villalaín J Biochim Biophys Acta; 2009 Oct; 1788(10):2183-93. PubMed ID: 19698697 [TBL] [Abstract][Full Text] [Related]
16. Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity. Haro I; Gómara MJ; Galatola R; Domènech O; Prat J; Girona V; Busquets MA Biochim Biophys Acta; 2011 Jun; 1808(6):1567-73. PubMed ID: 21377446 [TBL] [Abstract][Full Text] [Related]
17. A Langmuir monolayer study of the interaction of E1(145-162) hepatitis G virus peptide with phospholipid membranes. Sánchez-Martín MJ; Haro I; Alsina MA; Busquets MA; Pujol M J Phys Chem B; 2010 Jan; 114(1):448-56. PubMed ID: 20000622 [TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterisation of four peptide sequences related to thrombospondin-1B. Reig F; Ortiz A; Alsina MA J Colloid Interface Sci; 2011 Jun; 358(1):167-74. PubMed ID: 21420687 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a putative fusogenic sequence in the E2 hepatitis G virus protein. Larios C; Casas J; Alsina MA; Mestres C; Gómara MJ; Haro I Arch Biochem Biophys; 2005 Oct; 442(2):149-59. PubMed ID: 16165082 [TBL] [Abstract][Full Text] [Related]
20. Interaction of synthetic peptides corresponding to hepatitis G virus (HGV/GBV-C) E2 structural protein with phospholipid vesicles. Larios C; Christiaens B; Gómara MJ; Alsina MA; Haro I FEBS J; 2005 May; 272(10):2456-66. PubMed ID: 15885095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]